Insulin syringe, fixed-needle
Access comprehensive regulatory information for Insulin syringe, fixed-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Mondeal P/L, manufactured by Shina Corporation in South Korea. The device registration started on July 17, 2020.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Insulin syringe, fixed-needle
Australia TGA ARTG Registered Device
Good Name: Mondeal P/L - Insulin syringe, fixed-needle
Intended Purpose
to administer an injection of insulin to a patient subcutaneously
Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
July 17, 2020
Effective Date
July 17, 2020
Sponsor
Name
Mondeal P/LManufacturer
Country
South Korea
Address
8-26 Bojeodong-gil Useong-myeon, Gongji-si, Chungcheongnam-do